Integrated Maternity Care for Reducing Maternal Morbidity
(ENHANCED Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.
What data supports the effectiveness of the treatment Maternity care home model (MCHM)?
The patient-centered medical home model, similar to the Maternity Care Home Model, has been shown to improve continuity of care and enhance access, which are important for better health outcomes. Additionally, midwifery-led units, which are part of integrated maternity care, are associated with better perinatal outcomes and higher satisfaction among users and professionals.12345
How is the Maternity Care Home Model treatment different from other maternity care treatments?
The Maternity Care Home Model (MCHM) is unique because it integrates various aspects of maternity care into a single, coordinated approach, focusing on continuity of care and shared decision-making, which are not always emphasized in traditional maternity care models. This model aims to improve the quality and value of maternity care by making it a national policy priority and using performance measures to ensure high standards.56789
What is the purpose of this trial?
The goal of this randomized controlled intervention trial is to evaluate an integrated, interdisciplinary, multi-level maternity care home model (MCHM) aimed at reducing severe maternal morbidity (SMM) among a group of Black indigenous and people of color (BIPOC) patients.The main question it aims to answer is whether a patient-centered MCHM will address the gap in social, structural, and health system factors that contribute to disparities for the most vulnerable patients, thereby reducing SMM.Participants will be randomized to a MCHM (office-based prenatal care that is integrated with social services within the MCHM) or standard of care (office-based prenatal care with individually outsourced social services referrals) and followed during pregnancy through 1 year postpartum.
Research Team
Sindhu K Srinivas, MD, MSCE
Principal Investigator
University of Pennsylvania
Eligibility Criteria
This trial is for BIPOC patients experiencing perinatal morbidity. It's designed to help those who are pregnant and will follow them through one year after giving birth. The study seeks participants willing to be randomly assigned to different types of prenatal care.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive office-based prenatal care integrated with comprehensive social services within the maternity care home model or standard of care with individually outsourced social services referrals
Follow-up
Participants are monitored for severe maternal morbidity and other outcomes from delivery to 1 year postpartum
Postpartum Care
Participants attend routine postpartum visits and are assessed for various outcomes including lactation continuation and postpartum depression
Treatment Details
Interventions
- Maternity care home model (MCHM)
Maternity care home model (MCHM) is already approved in United States for the following indications:
- Reducing severe maternal morbidity (SMM) among Black indigenous and people of color (BIPOC) patients
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pennsylvania
Lead Sponsor
National Institute of Nursing Research (NINR)
Collaborator